The protective effects of melatonin postconditioning in cerebral ischemia may be mediated through the modulation of FUNDC1 and Bnip3 levels

dc.contributor.authorAslan, Gulnur
dc.contributor.authorBulmus, Ozgur
dc.contributor.authorTuzcu, Mehmet
dc.contributor.authorGokdere, Ebru
dc.contributor.authorSahna, Kezban Can
dc.contributor.authorŞahin, Kazım
dc.contributor.authorSahna, Engin
dc.date.accessioned2026-08-12T17:28:38Z
dc.date.issued2026
dc.departmentFırat Üniversitesi
dc.description.abstractObjectiveThe regulation of mitochondrial bioenergetics - as one of the endogenous defense mechanisms against ischemia-reperfusion (IR) injury - has been considered promising. This study aimed to determine which mitophagy-related signaling pathways (parkin, Bnip3, or FUNDC1) mediate the protective effects of postconditioning (PostC) and melatonin, both of which enhance the intrinsic defense capacity of cerebral tissue. In addition, microRNA-137 and microRNA-145, as well as serum asprosin, a novel glucogenic adipokine, levels were analyzed in cerebral IR injury.MethodRats were divided into four groups: control (sham), IR, IR+PostC and IR+Mel(n:10). After 90 minutes of occlusion, PostC was performed at the onset of reperfusion in three cycles of 30-sec reperfusion, followed by 10-sec ischemia. Results: All parameters involved in mitophagy pathways increased with IR in cerebral cortex, and serum asprosin level decreased. Parkin and PINK1 levels did not change due to the treatments, while the FUNDC1 and Bnip3 levels decreased and serum asprosin levels increased significantly compared to IR. MicroRNA-137 and microRNA-145 decreased, although treatment partially restored the levels of these microRNAs.ConclusionIncreased expressions of parkin/PINK1, FUNDC1 and Bnip3 may suggest that all mitophagy pathways are activated by cerebral IR. Melatonin PostC may protect the cerebral tissue by inhibiting BN & Idot;P3- and FUNDC1-mediated mitophagy.
dc.description.sponsorship318S080; Trkiye Bilimsel ve Teknolojik Arascedil;timath;rma Kurumu [318S040]
dc.description.sponsorshipThis work was supported by the 318S080; Turkiye Bilimsel ve Teknolojik Ara & scedil;t & imath;rma Kurumu [318S040].
dc.identifier.doi10.1080/02699052.2026.2638954
dc.identifier.issn0269-9052
dc.identifier.issn1362-301X
dc.identifier.pmid41789798
dc.identifier.scopus2-s2.0-105032103950
dc.identifier.scopusqualityQ3
dc.identifier.urihttps://doi.org/10.1080/02699052.2026.2638954
dc.identifier.urihttps://hdl.handle.net/11508/55365
dc.identifier.wosWOS:001708016900001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofBrain Injury
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectIschemic postconditioning
dc.subjectmelatonin
dc.subjectasprosin
dc.subjectBnip3
dc.subjectFUNDC1
dc.subjectmicroRNA-137 and-145
dc.titleThe protective effects of melatonin postconditioning in cerebral ischemia may be mediated through the modulation of FUNDC1 and Bnip3 levels
dc.typeArticle

Dosyalar